Herlapsa Tablet
Images are for reference. Actual packaging may vary.
Bottle of 30 tablets • TabletPrescription requiredSchedule H
Herlapsa Tablet
Lapatinib (250mg)
₹8057.00
Bottle of 30 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Lapatinib 250 mg
How It Works
Lapatinib inhibits the tyrosine kinase activity of the HER2 receptor, blocking downstream signaling pathways that promote cancer cell proliferation and survival.
Medicine Strength
250 mg
Uses & Benefits
Medical applications
Nausea
Herlapsa Tablet contains Lapatinib 250 mg, a tyrosine kinase inhibitor used primarily in the treatment of advanced or metastatic breast cancer that overexpresses the human epidermal growth factor receptor 2 (HER2). Lapatinib functions by selectively inhibiting the intracellular tyrosine kinase domains of both HER2 and epidermal growth factor receptor (EGFR), thereby blocking downstream signaling pathways involved in tumor cell proliferation and survival.
Read full descriptionShow less
This targeted mechanism of action makes Herlapsa effective in patients with HER2-positive breast cancer, particularly those who have progressed following prior therapies such as trastuzumab and chemotherapy. The tablet is indicated for use in combination with capecitabine or as monotherapy in cases where other treatments are unsuitable. Common adverse effects include diarrhea, rash, nausea, fatigue, and hepatotoxicity, necessitating regular monitoring of liver function tests during therapy.
Dose adjustments may be required based on tolerability and hepatic function. Herlapsa should be administered under the supervision of an oncologist experienced in cancer chemotherapy. It is contraindicated in patients with known hypersensitivity to Lapatinib or any tablet excipients. Caution is advised during pregnancy and lactation due to potential teratogenic effects. Proper patient counseling on adherence and side effect management is essential for optimal therapeutic outcomes.
Dosage & How to Use
How to use Herlapsa Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Herlapsa Tablet is to be taken empty stomach.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
It is not known whether it is safe to consume alcohol with Herlapsa Tablet. Please consult your doctor.
High Risk
Pregnancy
Herlapsa Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Driving
Herlapsa Tablet may cause side effects which could affect your ability to drive.
Exercise Caution
Liver
Herlapsa Tablet should be used with caution in patients with liver disease. Dose adjustment of Herlapsa Tablet may be needed. Please consult your doctor. Limited information is available on the use of this medicine in patients with the severe liver disease.
Regular Checkup
Breastfeeding
Herlapsa Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Herlapsa Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Herlapsa Tablet may be needed. Please consult your doctor. Limited information is available on the use of Herlapsa Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Herlapsa Tablet
